Home
>
National Drug Code (NDC)
>
MAXARON
MAXARON - 11528-135-01 - (IRON, ASCORBIC ACID, METHYLCOBALAMIN, and LEVOMEFOLATE CALCIUM)
Drug Information of MAXARON
| Product NDC: | 11528-135 |
| Proprietary Name: | MAXARON |
| Non Proprietary Name: | IRON, ASCORBIC ACID, METHYLCOBALAMIN, and LEVOMEFOLATE CALCIUM |
| Active Ingredient(s): | 200; 150; 1.13; 250 mg/1; mg/1; mg/1; ug/1 & nbsp; IRON, ASCORBIC ACID, METHYLCOBALAMIN, and LEVOMEFOLATE CALCIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of MAXARON
| Product NDC: | 11528-135 |
| Labeler Name: | CENTRIX PHARMACEUTICAL, INC, |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20071201 |
Package Information of MAXARON
| Package NDC: | 11528-135-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE, PLASTIC (11528-135-01) |
NDC Information of MAXARON
| NDC Code | 11528-135-01 |
| Proprietary Name | MAXARON |
| Package Description | 100 CAPSULE in 1 BOTTLE, PLASTIC (11528-135-01) |
| Product NDC | 11528-135 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | IRON, ASCORBIC ACID, METHYLCOBALAMIN, and LEVOMEFOLATE CALCIUM |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20071201 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | CENTRIX PHARMACEUTICAL, INC, |
| Substance Name | ASCORBIC ACID; IRON; LEVOMEFOLATE CALCIUM; METHYLCOBALAMIN |
| Strength Number | 200; 150; 1.13; 250 |
| Strength Unit | mg/1; mg/1; mg/1; ug/1 |
| Pharmaceutical Classes |
